Skip to main content

Dilated Cardiomyopathy and Steps in the Treatment

  • Conference paper
  • 98 Accesses

Part of the book series: Topics in Anaesthesia and Critical Care ((TIACC))

Abstract

Idiopathic dilated cardiomyopathy (IDC) is a heart muscle disease of unknown origin characterized by enlargement and systolic dysfunction of the left ventricle, with or without overt cardiac failure. Although IDC remains a serious condition with significant morbidity and mortality [1–6], an improving prognosis has been shown in recent years [7–10] and the favourable effect of new treatments on the survival of patients is impressive [9, 10]. Moreover, a progressive increase in the number of patients with IDC and a shorter duration of symptoms before diagnosis were found [7–10], suggesting that a more extensive and earlier detection of the disease may have contributed to modifying the natural history of IDC.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   34.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fuster V, Gersh BJ, Giuliani ER et al (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47: 525–531

    Article  PubMed  CAS  Google Scholar 

  2. Franciosa JA, Wilen M, Ziesche S et al (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51: 831–836

    Article  PubMed  CAS  Google Scholar 

  3. Unverferth DV, Magorien RD, Moeschberger ML et al (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152

    Article  PubMed  CAS  Google Scholar 

  4. Costanzo-Nordin MR, O’Connel JB, Engelmeier RS et al (1985) Dilated cardiomyopathy: funtional status, hemodynamics, arrhythmias, and prognosis. Cathet Cardiovasc D iagn 11: 445–4530

    Article  CAS  Google Scholar 

  5. Diaz RA, Obasohan A, Oakley CM (1987) Prediction of outcome in dilated cardiomyopathy. Br Heart J 58: 393–399

    Article  PubMed  CAS  Google Scholar 

  6. Stevenson LW, Fowler MB, Schroeder JS et al (1987) Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Med 83: 871–876

    Article  PubMed  CAS  Google Scholar 

  7. Codd MB, Sugrue DD, Gersh BJ et al (1989) Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984. Circulation 80: 564–572

    Article  PubMed  CAS  Google Scholar 

  8. Sugrue DD, Rodeheffer RJ, Codd MB et al (1992) The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med 117: 117–123

    Google Scholar 

  9. Redfield MM, Gersh BJ, Bailey KR et al (1993) Natural history of idiopathic dilated cardiomyopathy: effect of referral bias and secular trend. J Am Coll Cardiol 22: 1921–1926

    Article  PubMed  CAS  Google Scholar 

  10. Di Lenarda A, Secoli G, Perkan A et al (1994) Changing mortality in dilated cardiomyopathy. Br Heart J 72 [suppl]: S46–551

    Article  PubMed  Google Scholar 

  11. Gavazzi A, Lanzarini L, Cornalba C et al (1984) Dilated (congestive) cardiomyopathy. G Ital Cardiol 12: 492–498

    Google Scholar 

  12. Komajda M, Jais JP, Reeves F et al (1990) Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J 11: 824–831

    PubMed  CAS  Google Scholar 

  13. Razzolini R, Boffa GM, Stritoni P et al (1989) Storia naturale delle miocardiopatie dilatative. G Rai Cardiol 19: 114–120

    CAS  Google Scholar 

  14. Fowles RE (1990) Natural history and prognosis of overt dilated cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF (eds) Advances in cardiomyopathies. Springer, Berlin Heidelberg New York, pp 337–346

    Chapter  Google Scholar 

  15. Captopril Multicenter Research Group (1983) A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 24: 755–763

    Google Scholar 

  16. Furberg CD, Yusuf S (1985) Effect of vasodilatators on survival in chronic congestive heart failure. Am J Cardiol 55: 1110–1113

    Article  PubMed  CAS  Google Scholar 

  17. Cohn JN, Archibald DG, Ziesche S (1986) Effect of vasodilatator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 314: 1547–1552

    Article  PubMed  CAS  Google Scholar 

  18. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1435

    Article  Google Scholar 

  19. The Captopril-Digoxin Multicenter Research Group (1988) Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 259: 539–544

    Article  Google Scholar 

  20. Cohn JN, Johnson G (1990) Heart failure with normal ejection fraction: the V-HeFT study. Circulation 811Suppl III]: 48–53

    Google Scholar 

  21. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302

    Article  Google Scholar 

  22. Cohn JN, Johnson G, Ziesche S et al (1991) A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325: 303–310

    Article  PubMed  CAS  Google Scholar 

  23. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691

    Article  Google Scholar 

  24. Pfeffer MA, Braunwald E, Moyè LA et al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677

    Article  PubMed  CAS  Google Scholar 

  25. Carson P, Johnson G, Fletcher R et al (1996) Mild systolic dysfunction in heart failure (left venticular ejection fraction 35%): baseline characteristics, prognosis and response to therapy in the vasodilatator in heart failure trials (V-HeFT). J Am Coll Cardiol 27 (3): 642–649

    Article  PubMed  CAS  Google Scholar 

  26. Waagstein F, Bristow MR, Swedberg K et al (1993) Beneficial effects of metoprolol in dilated cardiomyopathy. Lancet 342: 1441–1446

    Article  PubMed  CAS  Google Scholar 

  27. CIBIS Investigators and Committees (1994) A randomized trial of beta-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90: 17651773

    Google Scholar 

  28. Packer M, Bristow MR, Cohn JN et al (1996) For the US Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349–1355

    Google Scholar 

  29. CIBIS II Investigators and Committees (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353: 9–13

    Article  Google Scholar 

  30. Merit HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metropol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353: 2001–2007

    Google Scholar 

  31. Steimle AE, Stevenson LW, Fonarow GC et al (1994) Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 23: 553559

    Google Scholar 

  32. Daly K, Richardson PJ, Olsen EGJ et al (1984) Acute myoacarditis-role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J 51: 30–35

    Article  PubMed  CAS  Google Scholar 

  33. Dec GW, Igor FP, Fallon JT et al (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies-clinical features, histologic correlates and clinical outcome. N Engl J Med 312: 885–890

    Article  PubMed  Google Scholar 

  34. Mortensen SA, Baandrup U, Buch J et al (1985) Immunosuppressive therapy of biopsy proven myocarditis: experiences with corticosteroids and cyclosporine. Int J Immunother 1: 35–45

    Google Scholar 

  35. Quigley PJ, Richardson PJ, Meany BT et al (1987) Long-term follow-up of acute myocarditis: correlation of ventricular function and outcome. Eur Heart J 8 [Suppl J]: 39–42

    Article  Google Scholar 

  36. Salvi A, Hrovatin E, Dreas L et al (1987) Changes in histology and left ventricular ejection fraction during immunosuppressive treatment in active myocarditis. Eur Heart J 8 [Suppl J]: 267–269

    Article  Google Scholar 

  37. Anguita M, Arizon JM, Bueno G et al (1992) Spontaneous clinical and hemodynamic improvement in patients on waiting list for heart transplantation. Chest 102: 96–99

    Article  PubMed  CAS  Google Scholar 

  38. Rokman HA, Adamson RM, Dembitsky WP et al. (1991) Acute fulminant myocarditis: long term follow-up after circulatory support with left ventricular assist device. Am Heart J 121: 922–926

    Article  Google Scholar 

  39. Stevenson LW (1996) Timing of adult cardiac transplantation. Cardiologia 41: 117–128

    PubMed  CAS  Google Scholar 

  40. Redfield MM, Gersh BJ, Bailey KR et al (1994) Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy. Am J Cardiol 74: 737–739

    Article  PubMed  CAS  Google Scholar 

  41. Di Lenarda A, Gregori D, Sinagra G et al (1996) Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? J Cardiac Failure 2 (2): 87–102

    Article  Google Scholar 

  42. World Health Organization/International Society and Federation of Cardiology (1980) Task force on the definition and classification of cardiomyopathies. Br Heart J 44: 672–673

    Article  Google Scholar 

  43. Report of the 1995 World Health Organization/International Society and Federation of Cardiology (1996) Task force on the definition and classification of cardiomyopathies. Circulation 93: 841–843

    Article  Google Scholar 

  44. Di Lenarda A, Gregori D, Lardieri G et al (1995) Progressiva riduzione della risposta al trattamento in pazienti con cardiomiopatia dilatativa e lunga storia di scompenso cardiaco. G Ital Cardiol; 25 [suppl 1J: 331

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Italia

About this paper

Cite this paper

Sinagra, G., Di Lenarda, A., Sabbadini, G. (2001). Dilated Cardiomyopathy and Steps in the Treatment. In: Atlee, J.L., Vincent, JL. (eds) Critical Care Cardiology in the Perioperative Period. Topics in Anaesthesia and Critical Care. Springer, Milano. https://doi.org/10.1007/978-88-470-2955-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2955-2_11

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0133-6

  • Online ISBN: 978-88-470-2955-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics